Cargando…

Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience

SIMPLE SUMMARY: We report the first clinical use of Endosight, a new guidance system for percutaneous interventional procedures based on augmented reality, to guide percutaneous thermal ablations. The new system was demonstrated to be precise and reliable, with a targeting accuracy of 3.4 mm. Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Solbiati, Marco, Ierace, Tiziana, Muglia, Riccardo, Pedicini, Vittorio, Iezzi, Roberto, Passera, Katia M., Rotilio, Alessandro C., Goldberg, S. Nahum, Solbiati, Luigi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909771/
https://www.ncbi.nlm.nih.gov/pubmed/35267620
http://dx.doi.org/10.3390/cancers14051312
_version_ 1784666269185736704
author Solbiati, Marco
Ierace, Tiziana
Muglia, Riccardo
Pedicini, Vittorio
Iezzi, Roberto
Passera, Katia M.
Rotilio, Alessandro C.
Goldberg, S. Nahum
Solbiati, Luigi A.
author_facet Solbiati, Marco
Ierace, Tiziana
Muglia, Riccardo
Pedicini, Vittorio
Iezzi, Roberto
Passera, Katia M.
Rotilio, Alessandro C.
Goldberg, S. Nahum
Solbiati, Luigi A.
author_sort Solbiati, Marco
collection PubMed
description SIMPLE SUMMARY: We report the first clinical use of Endosight, a new guidance system for percutaneous interventional procedures based on augmented reality, to guide percutaneous thermal ablations. The new system was demonstrated to be precise and reliable, with a targeting accuracy of 3.4 mm. Clinically acceptable, rapid setup and procedural times can be achieved. ABSTRACT: Background: Over the last two decades, augmented reality (AR) has been used as a visualization tool in many medical fields in order to increase precision, limit the radiation dose, and decrease the variability among operators. Here, we report the first in vivo study of a novel AR system for the guidance of percutaneous interventional oncology procedures. Methods: Eight patients with 15 liver tumors (0.7–3.0 cm, mean 1.56 + 0.55) underwent percutaneous thermal ablations using AR guidance (i.e., the Endosight system). Prior to the intervention, the patients were evaluated with US and CT. The targeted nodules were segmented and three-dimensionally (3D) reconstructed from CT images, and the probe trajectory to the target was defined. The procedures were guided solely by AR, with the position of the probe tip was subsequently confirmed by conventional imaging. The primary endpoints were the targeting accuracy, the system setup time, and targeting time (i.e., from the target visualization to the correct needle insertion). The technical success was also evaluated and validated by co-registration software. Upon completion, the operators were assessed for cybersickness or other symptoms related to the use of AR. Results: Rapid system setup and procedural targeting times were noted (mean 14.3 min; 12.0–17.2 min; 4.3 min, 3.2–5.7 min, mean, respectively). The high targeting accuracy (3.4 mm; 2.6–4.2 mm, mean) was accompanied by technical success in all 15 lesions (i.e., the complete ablation of the tumor and 13/15 lesions with a >90% 5-mm periablational margin). No intra/periprocedural complications or operator cybersickness were observed. Conclusions: AR guidance is highly accurate, and allows for the confident performance of percutaneous thermal ablations.
format Online
Article
Text
id pubmed-8909771
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89097712022-03-11 Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience Solbiati, Marco Ierace, Tiziana Muglia, Riccardo Pedicini, Vittorio Iezzi, Roberto Passera, Katia M. Rotilio, Alessandro C. Goldberg, S. Nahum Solbiati, Luigi A. Cancers (Basel) Article SIMPLE SUMMARY: We report the first clinical use of Endosight, a new guidance system for percutaneous interventional procedures based on augmented reality, to guide percutaneous thermal ablations. The new system was demonstrated to be precise and reliable, with a targeting accuracy of 3.4 mm. Clinically acceptable, rapid setup and procedural times can be achieved. ABSTRACT: Background: Over the last two decades, augmented reality (AR) has been used as a visualization tool in many medical fields in order to increase precision, limit the radiation dose, and decrease the variability among operators. Here, we report the first in vivo study of a novel AR system for the guidance of percutaneous interventional oncology procedures. Methods: Eight patients with 15 liver tumors (0.7–3.0 cm, mean 1.56 + 0.55) underwent percutaneous thermal ablations using AR guidance (i.e., the Endosight system). Prior to the intervention, the patients were evaluated with US and CT. The targeted nodules were segmented and three-dimensionally (3D) reconstructed from CT images, and the probe trajectory to the target was defined. The procedures were guided solely by AR, with the position of the probe tip was subsequently confirmed by conventional imaging. The primary endpoints were the targeting accuracy, the system setup time, and targeting time (i.e., from the target visualization to the correct needle insertion). The technical success was also evaluated and validated by co-registration software. Upon completion, the operators were assessed for cybersickness or other symptoms related to the use of AR. Results: Rapid system setup and procedural targeting times were noted (mean 14.3 min; 12.0–17.2 min; 4.3 min, 3.2–5.7 min, mean, respectively). The high targeting accuracy (3.4 mm; 2.6–4.2 mm, mean) was accompanied by technical success in all 15 lesions (i.e., the complete ablation of the tumor and 13/15 lesions with a >90% 5-mm periablational margin). No intra/periprocedural complications or operator cybersickness were observed. Conclusions: AR guidance is highly accurate, and allows for the confident performance of percutaneous thermal ablations. MDPI 2022-03-03 /pmc/articles/PMC8909771/ /pubmed/35267620 http://dx.doi.org/10.3390/cancers14051312 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Solbiati, Marco
Ierace, Tiziana
Muglia, Riccardo
Pedicini, Vittorio
Iezzi, Roberto
Passera, Katia M.
Rotilio, Alessandro C.
Goldberg, S. Nahum
Solbiati, Luigi A.
Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience
title Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience
title_full Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience
title_fullStr Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience
title_full_unstemmed Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience
title_short Thermal Ablation of Liver Tumors Guided by Augmented Reality: An Initial Clinical Experience
title_sort thermal ablation of liver tumors guided by augmented reality: an initial clinical experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909771/
https://www.ncbi.nlm.nih.gov/pubmed/35267620
http://dx.doi.org/10.3390/cancers14051312
work_keys_str_mv AT solbiatimarco thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT ieracetiziana thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT mugliariccardo thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT pedicinivittorio thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT iezziroberto thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT passerakatiam thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT rotilioalessandroc thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT goldbergsnahum thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience
AT solbiatiluigia thermalablationoflivertumorsguidedbyaugmentedrealityaninitialclinicalexperience